EcoDrugPlus

Ensembl ID : ENSOCUG00000022442
Gene Symbol: LOC100345694
2 Cross references
62 Possible Orthologues:

Ensembl ID : ENSOCUG00000025034
Gene Symbol: LOC100337691
2 Cross references
34 Possible Orthologues:

Ensembl ID : ENSOCUG00000002095
Gene Symbol: NR1H3
2 Cross references
391 Possible Orthologues:

Ensembl ID : ENSOCUG00000026336
Gene Symbol: LOC100345774
2 Cross references
154 Possible Orthologues:

Ensembl ID : ENSOCUG00000003336
Gene Symbol: RPS6
2 Cross references
127 Possible Orthologues:

Ensembl ID : ENSOCUG00000014849
Gene Symbol: CACNB2
2 Cross references
201 Possible Orthologues:

Ensembl ID : ENSOCUG00000027809
Gene Symbol: LOC100343733
2 Cross references
210 Possible Orthologues:

Ensembl ID : ENSOCUG00000025312
Gene Symbol: BCL2
2 Cross references
227 Possible Orthologues:

Ensembl ID : ENSOCUG00000022043
Gene Symbol: LOC100352536
2 Cross references
52 Possible Orthologues:

Ensembl ID : ENSOCUG00000024479
Gene Symbol: RPL15
2 Cross references
76 Possible Orthologues:

Ensembl ID : ENSOCUG00000024061
Gene Symbol: HMGB1
2 Cross references
239 Possible Orthologues:

Ensembl ID : ENSOCUG00000009905
Gene Symbol: RPL37A
2 Cross references
24 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).